Original Article

Effects of pulsed and continuous ultrasound therapy on olfactory disorders in COVID-19 patients

Abstract

Background and Objectives: Olfactory dysfunction is common in COVID-19 patients, with a pooled prevalence of up to 50%. This study investigated the efficacy of pulsed and continuous ultrasound treatment on olfactory disorders of these patients.
Materials and Methods: Three groups of COVID-19 patients having anosmia were studied, each including 15 patients. Pulsed ultrasound and continuous ultrasound were used to evaluate their efficacy on anosmia recovery in two groups of patients. The patients were subjected to pulsed or continuous ultrasound intervention 10 times during two weeks (5 days per week). The control group received no intervention. The SIT (Smell Identification Test) was used to assess the severity of olfactory dysfunctions of all patients on days 0 and 14. Data analysis was done using MANCOVA test.
Results: Totally 20 (44.4%) and 25 (55.6%) patients were affected by Delta and Omicron variants of COVID-19 virus. The SIT test results showed a significant improvement in olfactory recovery of all 30 patients except one after ultrasound treatment (p < 0.05), but this was not observed in the control group. Pulsed and continuous ultrasound treatment showed an almost equal effect on olfaction status.
Conclusion: Although there was no difference in olfactory test results in the control group during intervention period, pulsed and continuous ultrasound interventions were significantly effective in improving patients’ olfaction. Pulsed and continuous therapeutic ultrasound improved the COVID-19 related olfactory dysfunction and can be considered as a promising technique for postinfectious olfaction.

1. Moraschini V, Reis D, Sacco R, Calasans‐Maia MD. Prevalence of anosmia and ageusia symptoms among long‐term effects of COVID‐19. Oral Dis 2022; 28 Suppl 2: 2533-2537.
2. Zhang Y, Mei T, Chen Y, Wang L, Jiang L, Liu K, et al. Smell disorders in COVID-19 patients: role of olfactory training: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021; 100(8): e24862.
3. Sheen F, Tan V, Haldar S, Sengupta S, Allen D, Somani J, et al. Evaluating the onset, severity, and recovery of changes to smell and taste associated with COVID-19 infection in a Singaporean population (the COVOSMIA-19 trial): protocol for a prospective case-control study. JMIR Res Protoc 2020; 9(12): e24797.
4. Mastrangelo A, Bonato M, Cinque P. Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes. Neurosci Lett 2021; 748: 135694.
5. Nakhostin-Ansari A, Nazem A, Ansari NN, Fathali M, Naghdi S, Hasson S. Effects of pulsed ultrasound on olfactory dysfunction in patients with chronic rhinosinusitis: A pilot study. Complement Ther Clin Pract 2021; 44: 101409.
6. Feizabadi N, Sarrafzadeh J, Fathali M, Vasaghi-Gharamaleki B, Dadgoo M, Kazemian H, et al. Quantitative analysis of Staphylococcus aureus in patients with chronic rhinosinusitis under continuous ultrasound treatment. Iran J Microbiol 2018; 10: 354-360.
7. Feizabadi N, Sarrafzadeh J, Fathali M, Vasaghi-Gharamaleki B, Dadgoo M, Kardan-Yamchi J, et al. The pulsed ultrasound strategy effectively decreases the S. aureus population of chronic rhinosinusitis patients. BMC Res Notes 2019; 12: 576.
8. Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R, editors. Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin Proc 2020; 95: 1621-1631.
9. Rocke J, Hopkins C, Philpott C, Kumar N. Is loss of sense of smell a diagnostic marker in COVID‐19: a systematic review and meta‐analysis. Clin Otolaryngol 2020; 45: 914-922.
10. Whitcroft KL, Hummel T. Olfactory dysfunction in COVID-19: diagnosis and management. JAMA 2020; 323: 2512-2514.
11. Oleszkiewicz A, Hanf S, Whitcroft KL, Haehner A, Hummel T. Examination of olfactory training effectiveness in relation to its complexity and the cause of olfactory loss. Laryngoscope 2018; 128: 1518-1522.
12. Konstantinidis I, Tsakiropoulou E, Constantinidis J. Long term effects of olfactory training in patients with post-infectious olfactory loss. Rhinology 2016; 54: 170-175.
13. Altundag A, Cayonu M, Kayabasoglu G, Salihoglu M, Tekeli H, Saglam O, et al. Modified olfactory training in patients with postinfectious olfactory loss. Laryngoscope 2015; 125: 1763-1766.
14. Whitcroft KL, Hummel T. Clinical diagnosis and current management strategies for olfactory dysfunction: a review. JAMA Otolaryngol Head Neck Surg 2019; 145: 846-853.
15. Jiang R-S, Wu S-H, Liang K-L, Shiao J-Y, Hsin C-H, Su M-C. Steroid treatment of posttraumatic anosmia. Eur Arch Otorhinolaryngol 2010; 267: 1563-1567.
16. Whitcroft KL, Ezzat M, Cuevas M, Andrews P, Hummel T. The effect of intranasal sodium citrate on olfaction in post‐infectious loss: results from a prospective, placebo‐controlled trial in 49 patients. Clin Otolaryngol 2017; 42: 557-563.
17. Hummel T, Whitcroft KL, Rueter G, Haehner A. Intranasal vitamin A is beneficial in post-infectious olfactory loss. Eur Arch Otorhinolaryngol 2017; 274: 2819-2825.
18. Reden J, Lill K, Zahnert T, Haehner A, Hummel T. Olfactory function in patients with postinfectious and posttraumatic smell disorders before and after treatment with vitamin A: a double‐blind, placebo‐controlled, randomized clinical trial. Laryngoscope 2012; 122: 1906-1909.
Files
IssueVol 17 No 6 (2025) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijm.v17i6.20377
Keywords
Olfactory dysfunction Pulsed ultrasound Continuous ultrasound COVID-19 SIT (Smell identification test)
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Feizabadi N, Rostamian A, Nakhostin Ansari N, Moghimi E, Norouzi M. Effects of pulsed and continuous ultrasound therapy on olfactory disorders in COVID-19 patients. Iran J Microbiol. 2025;17(6):1059-1063.